ArticleJournal of neuroinflammation2011

Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.

Noemí Virgili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.